Terms: = Leukemia AND PCM1, Q15154, PTC4, ENSG00000078674, 5108
44 results:
1. Application of droplet digital PCR in minimal residual disease monitoring of rare fusion transcripts and mutations in haematological malignancies.
Ip BBK; Wong ATC; Law JHY; Au CH; Ma SY; Chim JCS; Liang RHS; Leung AYH; Wan TSK; Ma ESK
Sci Rep; 2024 Mar; 14(1):6400. PubMed ID: 38493200
[TBL] [Abstract] [Full Text] [Related]
2. Mediators of Black-White inequities in cardiovascular mortality among survivors of 18 cancers in the USA.
Sung H; Hyun N; Ohman RE; Yang EH; Siegel RL; Jemal A
Int J Epidemiol; 2024 Feb; 53(1):. PubMed ID: 37471575
[TBL] [Abstract] [Full Text] [Related]
3. The international consensus classification of eosinophilic disorders and systemic mastocytosis.
Wang SA; Orazi A; Gotlib J; Reiter A; Tzankov A; Hasserjian RP; Arber DA; Tefferi A
Am J Hematol; 2023 Aug; 98(8):1286-1306. PubMed ID: 37283522
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathologic characteristics, genetic features, and treatment options for acute lymphoblastic leukemia with JAK2 rearrangement-A 10-case study and literature review.
Zhang L; Shah B; Zhang Y; Tashkandi H; Xiao W; Fernandez-Pol S; Vergara-Lluri M; Hussaini M; Song J; Lancet J; Moscinski L; Yun S; Lu CM; Medeiros LJ; Tang G
Hum Pathol; 2023 Jun; 136():1-15. PubMed ID: 36958463
[TBL] [Abstract] [Full Text] [Related]
5. Updates on eosinophilic disorders.
Tzankov A; Reichard KK; Hasserjian RP; Arber DA; Orazi A; Wang SA
Virchows Arch; 2023 Jan; 482(1):85-97. PubMed ID: 36068374
[TBL] [Abstract] [Full Text] [Related]
6. Genetically Predicted Circulating Levels of Cytokines and the Risk of Cancer.
Song J; Li A; Qian Y; Liu B; Lv L; Ye D; Sun X; Mao Y
Front Immunol; 2022; 13():886144. PubMed ID: 35865545
[TBL] [Abstract] [Full Text] [Related]
7. pcm1-JAK2 Fusion Tyrosine Kinase Gene-Related Neoplasia: A Systematic Review of the Clinical Literature.
Kaplan HG; Jin R; Bifulco CB; Scanlan JM; Corwin DR
Oncologist; 2022 Aug; 27(8):e661-e670. PubMed ID: 35472244
[TBL] [Abstract] [Full Text] [Related]
8. Myeloid Neoplasm with pcm1-PDGFRB Transcript Responded to Low-Dose Imatinib: One Case Report with Literature Review.
Wang Z; Wan L; Lin D; Li CW; Tian Z; Mi YC
Acta Haematol; 2022; 145(5):560-565. PubMed ID: 35340014
[TBL] [Abstract] [Full Text] [Related]
9. World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management.
Shomali W; Gotlib J
Am J Hematol; 2022 Jan; 97(1):129-148. PubMed ID: 34533850
[TBL] [Abstract] [Full Text] [Related]
10. Myeloid/lymphoid neoplasms with FLT3 rearrangement.
Tang G; Tam W; Short NJ; Bose P; Wu D; Hurwitz SN; Bagg A; Rogers HJ; Hsi ED; Quesada AE; Wang W; Miranda RN; Bueso-Ramos CE; Medeiros LJ; Nardi V; Hasserjian RP; Arber DA; Orazi A; Foucar K; Wang SA
Mod Pathol; 2021 Sep; 34(9):1673-1685. PubMed ID: 33990705
[TBL] [Abstract] [Full Text] [Related]
11. Clinical and Molecular Approach to Adult-Onset, Neoplastic Monocytosis.
Shallis RM; Siddon AJ; Zeidan AM
Curr Hematol Malig Rep; 2021 Jun; 16(3):276-285. PubMed ID: 33890194
[TBL] [Abstract] [Full Text] [Related]
12. Myeloid/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or FGFR1 or With pcm1-JAK2.
Pozdnyakova O; Orazi A; Kelemen K; King R; Reichard KK; Craig FE; Quintanilla-Martinez L; Rimsza L; George TI; Horny HP; Wang SA
Am J Clin Pathol; 2021 Feb; 155(2):160-178. PubMed ID: 33367495
[TBL] [Abstract] [Full Text] [Related]
13. Myeloid/lymphoid neoplasms with eosinophilia and FLT3 rearrangement.
Shao H; Wang W; Song J; Tang G; Zhang X; Tang Z; Srivastava J; Shah B; Medeiros LJ; Zhang L
Leuk Res; 2020 Dec; 99():106460. PubMed ID: 33166908
[TBL] [Abstract] [Full Text] [Related]
14. Update on CML-Like Disorders.
Cross NCP
Clin Lymphoma Myeloma Leuk; 2020 Sep; 20 Suppl 1():S101-S102. PubMed ID: 32862848
[TBL] [Abstract] [Full Text] [Related]
15. Integrated genomic analysis using chromosomal microarray, fluorescence in situ hybridization and mate pair analyses: Characterization of a cryptic t(9;22)(p24.1;q11.2)/BCR-JAK2 in myeloid/lymphoid neoplasm with eosinophilia.
Snider JS; Znoyko I; Lindsey KG; Morse J; Baughn LB; Hoppman NL; Pitel BA; Pearce KE; Schandl CA; Wolff DJ
Cancer Genet; 2020 Aug; 246-247():44-47. PubMed ID: 32827877
[TBL] [Abstract] [Full Text] [Related]
16. Response to tyrosine kinase inhibitors in myeloid neoplasms associated with pcm1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes.
Schwaab J; Naumann N; Luebke J; Jawhar M; Somervaille TCP; Williams MS; Frewin R; Jost PJ; Lichtenegger FS; La Rosée P; Storch N; Haferlach T; Horny HP; Fabarius A; Haferlach C; Burchert A; Hofmann WK; Cross NCP; Hochhaus A; Reiter A; Metzgeroth G
Am J Hematol; 2020 Jul; 95(7):824-833. PubMed ID: 32279331
[TBL] [Abstract] [Full Text] [Related]
17. The diagnostic challenges and clinical course of a myeloid/lymphoid neoplasm with eosinophilia and
Lee WY; Pfau RB; Choi SM; Yang J; Xiao H; Putnam EM; Ryan RJ; Bixby DL; Shao L
Cold Spring Harb Mol Case Stud; 2020 Apr; 6(2):. PubMed ID: 32238402
[TBL] [Abstract] [Full Text] [Related]
18. A tricky and rare cause of pulmonary eosinophilia: myeloid/lymphoid neoplasm with eosinophilia and rearrangement of PDGFRA.
Zanelli M; Smith M; Zizzo M; Carloni A; Valli R; De Marco L; Foroni M; Palicelli A; Martino G; Ascani S
BMC Pulm Med; 2019 Nov; 19(1):216. PubMed ID: 31744552
[TBL] [Abstract] [Full Text] [Related]
19. World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management.
Shomali W; Gotlib J
Am J Hematol; 2019 Oct; 94(10):1149-1167. PubMed ID: 31423623
[TBL] [Abstract] [Full Text] [Related]
20. RNA Sequencing Analysis for the Identification of a pcm1/PDGFRB Fusion Gene Responsive to Imatinib.
Such E; Liquori A; Mora E; Marco-Ayala J; Avetisyan G; Regadera A; Ibañez F; Panadero J; Senent L; Llop M; Díaz A; Vicente A; Luna I; Ibáñez M; Barragán E; Sanz MA; Sanz G; Communidad Valenciana ; Cervera J
Acta Haematol; 2019; 142(2):92-97. PubMed ID: 31085913
[TBL] [Abstract] [Full Text] [Related]
[Next]
